Question 1

What specific benefits could the 68Ga-PFA2 PET imaging provide for my lung cancer diagnosis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors clinical trial (NCT07331532). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this imaging technique compare to standard imaging methods I might have already had?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors clinical trial (NCT07331532). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects associated with the 68Ga-PFA2 PET scan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors clinical trial (NCT07331532). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the results of this imaging affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors clinical trial (NCT07331532). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the timeline for participating in this study, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors clinical trial (NCT07331532). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors clinical trial (NCT07331532). Contact the study team or your healthcare provider for specific answers.

What this study is about